Laura Lovett

By Laura Lovett 02:13 pm July 16, 2020
Cityblock, a startup focused on used tech to tackling health disparities, has raised $53.5 million in what it describes as Series B+ funding. Kinnevik AB led the round with participation from AIMS Imprint of Goldman Sachs Asset Management and Alphabet, as well as existing investors.  This comes roughly a year after a $63 million Series B funding in April of 2019, and close to two years after the...
By Laura Lovett 03:16 pm July 15, 2020
Before Dr. Matthew Fradkin was a pediatrician he played in a punk rock band. Aside from the years of training to become a physician, he said there were actually some similarities to the two – namely the search for human connection. “They have the same core, the in-the-moment human connection is really important to both. Bringing back the human connection in medicine is where I see digital and AI...
By Laura Lovett 02:42 pm July 14, 2020
This morning digital pharmacy Medly announced the close of a $100 million Series B funding round. The new infusion of cash was led by Volition Capital and Greycroft with participation from Horsley Bridge and Lerer Hippeau. This comes roughly a year after the New York-based company announced the close of its Series A funding round, which was also led by Greycroft, for an undisclosed amount.  WHAT...
By Laura Lovett 01:31 pm July 14, 2020
Amazon continues making moves in their employee health space, today announcing the launch of a pilot program with Crossover Health that will give its local employees access to local health centers.  The pilot will start in the Dallas-Fort Worth area, and will be opened to Amazon employees and their families. Employees can visit the centers for primary care, chronic care, prescription medications...
By Laura Lovett 03:26 pm July 13, 2020
Swedish pharma company Orexo is jumping into the American digital-therapeutics game with the announcement of two new products, deprexis for treating depression symptoms and vorvida, a treatment for problematic alcohol use.  The new treatments are coming to the US market thanks to relaxed FDA regulations surrounding digital health products for psychiatric disorders, which was enacted as a result...
By Laura Lovett 02:20 pm July 13, 2020
VR for pain. A new study published by JMIR found that virtual reality was a feasible and scalable means of treating chronic pain. The study, which used AppliedVR’s technology, split participants into two groups: a VR cohort and an audio one.  Participants in the VR group were mailed a headset, with accompanying software, speakers and microphone. Participants in this group were asked to complete...
By Laura Lovett 02:10 pm July 9, 2020
Pharma giant Otsuka is rolling out a new kidney focused platform called NephU that provides online resources about nephrology conditions and a place for clinicians to collaborate and share information amongst themselves, and with patients.  Users will be able to tap into an online library of resources that include video, audio, webinars and podcasts. According to the site, the “community”...
By Laura Lovett 02:54 pm July 8, 2020
Chris Hogg, chief operations officer at digital respiratory company Propeller Health, announced on Twitter last week that he is leaving the company. “After 6 incredible years @PropellerHealth, today it is with very mixed emotions that I am saying goodbye,” he wrote on Twitter. “Propeller has been, by far, the best career experience of my life. I am proud of the team and all that we accomplished...
By Laura Lovett 01:33 pm July 8, 2020
Infertility is a fairly common problem in the US. The CDC reports that about 10 in every 100 women in the country has difficulty becoming or staying pregnant. This has given rise to the emerging ‘FemTech’ industry, and in particular fertility tech, digital products designed to support individuals looking to get pregnant. Recently, venture capital firm Octopus released a report outlining the...
By Laura Lovett 03:10 pm July 7, 2020
Novartis and respiratory health company Propeller Health, a ResMed subsidiary, have teamed up to co-package the latter’s digital health platform with the pharma giant’s new asthma medication Enerzair Breezhaler.  This news come shortly after the product landed European Commission clearance. The co-packaged product will be launching in the EU during 2020. However, it is not yet available in the U....